When viewing this topic in a different language, you may notice some differences in the way the content is structured, but it still reflects the latest evidence-based guidance.

Infantile spasms syndrome

Última revisão: 30 Nov 2025
Última atualização: 13 Dec 2024

Resumo

Definição

História e exame físico

Principais fatores diagnósticos

  • spasms
  • head nodding
  • neurodevelopmental delay or regression
Detalhes completos

Outros fatores diagnósticos

  • onset age 3-12 months
  • perinatal complication
  • abnormal eye movements
  • microcephaly
  • ash-leaf macules
  • motor system abnormalities
Detalhes completos

Fatores de risco

  • brain malformation
  • neurocutaneous abnormalities
  • prenatal or perinatal vascular event
  • intrauterine or perinatal infections
  • inherited metabolic disorder
  • genetic disorders
  • family history
  • neonatal sinovenous thrombosis
  • postnatal brain injury
  • brain tumors
Detalhes completos

Investigações diagnósticas

Primeiras investigações a serem solicitadas

  • sleep electroencephalogram (EEG)
  • complete blood count
  • blood chemistries
  • plasma glucose
  • serum calcium
  • serum magnesium
  • liver function tests
  • ammonia
  • blood gas
  • plasma lactate/pyruvate
  • plasma amino acids
  • urine organic acids
  • acylcarnitines (blood spot)
  • biotinidase
  • urine alpha-amino adipic semialdehyde dehydrogenase (AASA)
  • urine and plasma creatine and guanidinoacetate
  • next-generation sequencing: gene panel/whole-exome sequencing/whole-genome sequencing
  • microarray comparative genome hybridization (CGH)
  • brain MRI
Detalhes completos

Investigações a serem consideradas

  • cerebrospinal fluid (CSF) exam
  • thyroid function tests (free thyroxine [FT4], thyroid-stimulating hormone [TSH])
  • plasma transferrin glycoforms
  • very long-chain fatty acids
  • serum copper, ceruloplasmin
  • urine sulfocysteine
  • CT brain
  • cytomegalovirus (CMV) culture, polymerase chain reaction (PCR), or serology
  • toxoplasmosis serology
  • echocardiogram
  • renal ultrasound
  • ophthalmology exam
Detalhes completos

Algoritmo de tratamento

CONTÍNUA

all patients

Colaboradores

Autores

Robert Robinson, MA, MBBS, FRCP, PhD

Consultant Paediatric Neurologist

Great Ormond Street Hospital

London

UK

Declarações

RR declares that he has no competing interests.

Sarah Buts, MD

Clinical Fellow in Paediatric Neurology

Great Ormond Street Hospital

London

UK

Declarações

SB declares that she has no competing interests.

Agradecimentos

Dr Robert Robinson and Dr Sarah Buts would like to gratefully acknowledge Dr Katharina Vezyroglou, Dr Marjorie Illingworth, Dr Pradnya Gadgil, Dr Teesta Soman, and Dr Shelly Weiss, previous contributors to this topic.

Declarações

KV, MI, PG, TS, and SW declare that they have no competing interests.

Revisores

Gregory L. Holmes, MD

Section Chief of Neurology

Dartmouth-Hitchcock Medical Center

Lebanon

NH

Declarações

GLH declares that he has no competing interests.

Maria Roberta Cilio, MD, PhD

Attending Pediatric Neurologist

Division of Neurology

Bambino Gesu Children's Hospital

Rome

Italy

Declarações

MRC declares that she has no competing interests.

Lionel Carmant, MD

Professor of Neurology

Department of Pediatrics

University of Montreal

Director of Epilepsy Clinic and Research Group

Saint Justine Hospital

Montreal

QC

Canada

Declarações

LC declares that he has no competing interests.

Créditos aos pareceristas

Os tópicos do BMJ Best Practice são constantemente atualizados, seguindo os desenvolvimentos das evidências e das diretrizes. Os pareceristas aqui listados revisaram o conteúdo pelo menos uma vez durante a história do tópico.

Declarações

As afiliações e declarações dos pareceristas referem--se ao momento da revisão.

Referências

Nossas equipes internas de editoria e de evidências trabalham em conjunto com colaboradores internacionais especializados e pares revisores para garantir que forneçamos acesso às informações o mais clinicamente relevantes possível.

Principais artigos

Hancock EC, Osborne JP, Edwards SW. Treatment of infantile spasms. Cochrane Database Syst Rev. 2013 Jun 5;(6):CD001770.Texto completo  Resumo

Go CY, Mackay MT, Weiss SK, et al; Child Neurology Society; American Academy of Neurology. Evidence-based guideline update: medical treatment of infantile spasms. Neurology. 2012 Jun 12;78(24):1974-80.Texto completo  Resumo

Lux AL, Edwards SW, Hancock E, et al. The United Kingdom Infantile Spasms Study (UKISS) comparing hormone treatment with vigabatrin on developmental and epilepsy outcomes to age 14 months: a multicentre randomised trial. Lancet Neurol. 2005 Nov;4(11):712-7. Resumo

National Institute for Health and Care Excellence. Epilepsies in children, young people and adults. Apr 2022 [internet publication].Texto completo

O'Callaghan FJ, Edwards SW, Alber FD, et al. Safety and effectiveness of hormonal treatment versus hormonal treatment with vigabatrin for infantile spasms (ICISS): a randomised, multicentre, open-label trial. Lancet Neurol. 2017 Jan;16(1):33-42.Texto completo  Resumo

Willmore LJ, Abelson MB, Ben-Menachem E, et al. Vigabatrin: 2008 update. Epilepsia. 2009 Feb;50(2):163-73. Resumo

Artigos de referência

Uma lista completa das fontes referenciadas neste tópico está disponível para os usuários com acesso total ao BMJ Best Practice.
  • Infantile spasms syndrome images
  • Differentials

    • Dravet syndrome
    • Benign familial infantile seizures
    • Benign sleep myoclonus
    Mais Differentials
  • Guidelines

    • Evidence-based guideline update: medical treatment of infantile spasms
    • Infantile spasms: a US consensus report
    Mais Guidelines
  • Folhetos informativos para os pacientes

    Epilepsy: questions to ask your doctor

    Mais Folhetos informativos para os pacientes
  • padlock-lockedConectar-se ou assinar para acessar todo o BMJ Best Practice

O uso deste conteúdo está sujeito ao nosso aviso legal